Related Experiment Video
Updated: Aug 17, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Repeat thrombolysis for acute myocardial infarction
P Banerjee1, A L Clark, M S Norell
1Department of Cardiology, Castle Hill Hospital, Kingston upon Hull HU16 5JQ, UK. pbanerjee@ukonline.co.uk
Insights
Repeat thrombolysis for acute myocardial infarction identifies high-risk patients. While safe, these patients require close monitoring and potential early intervention, especially if initial treatment fails.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Research
Background:
- Thrombolysis is the primary treatment for acute myocardial infarction (AMI) in the UK.
- A significant number of AMI patients experience treatment failure or early re-infarction with initial thrombolysis.
- Optimal management for these patients remains unclear, with repeat thrombolysis often administered in non-interventional facilities.
Purpose of the Study:
- To evaluate the outcomes of repeat thrombolysis in AMI patients with failed initial treatment or early re-infarction.
- To compare the safety and efficacy of single versus multiple thrombolytic doses.
Main Methods:
- Retrospective analysis of 92 patients receiving two or more thrombolysis doses versus 98 patients receiving a single dose for AMI.
- Case note review to assess outcomes including death, heart failure, and need for revascularization.
Main Results:
- The repeat thrombolysis group showed significantly higher 30-day mortality (p=0.0016).
- Increased incidence of heart failure with lower ejection fraction and cardiac arrests observed in the rethrombolysed group.
- Hemorrhage rates were similar between groups; however, repeat thrombolysis led to more coronary angiography and percutaneous coronary interventions (PCIs).
Conclusions:
- Repeat thrombolysis identifies AMI patients at high risk for early complications.
- While repeat thrombolysis is safe, close monitoring and early intervention are crucial.
- Early referral to tertiary centers is recommended for patients in district general hospitals without interventional facilities.
Background:
Thrombolysis is still the first line of treatment for acute myocardial infarction in the United Kingdom. In a significant proportion of these patients thrombolytic therapy fails to restore patency of the occluded artery or is followed by early re-infarction. The best management of this group of patients is not clear although repeat doses of thrombolysis are commonly administered especially in the district general hospitals that do not have access to invasive facilities. We performed a retrospective clinical study to determine the outcome of repeat thrombolysis for acute myocardial infarction in patients with failed initial thrombolysis or early re-infarction.
Methods:
Ninety-two patients who received two or more doses of thrombolysis for acute myocardial infarction were compared with 98 contemporary similar patients who received only one dose of thrombolysis. Case notes of all patients were examined for retrospective analysis. Main outcome measures were death, heart failure and need for in-hospital revascularization.
Results:
Compared to the group thrombolysed once, in the rethrombolysed group there were significantly more deaths at 30 days (p=0.0016), more heart failure (with lower mean ejection fraction), more cardiac arrests as well as more frequent coronary angiography and percutaneous coronary interventions (PCIs). The incidence of haemorrhage in the two groups did not differ.
Conclusions:
The need for repeat thrombolysis identifies a group of patients with a high risk of early complications. Although repeat thrombolysis is safe, these patients then need close monitoring with a view to early intervention. For such patients admitted to district general hospitals without interventional facilities early referral to a tertiary center should be considered.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis III: Medical Management
Clot Retraction and Fibrinolysis
